TBC1D10A
Basic information
Region (hg38): 22:30291990-30326947
Previous symbols: [ "TBC1D10" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TBC1D10A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 32 | 35 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 32 | 2 | 1 |
Variants in TBC1D10A
This is a list of pathogenic ClinVar variants found in the TBC1D10A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-30292396-C-G | not specified | Uncertain significance (Dec 09, 2023) | ||
22-30292406-G-A | not specified | Uncertain significance (Jun 28, 2022) | ||
22-30292506-G-T | not specified | Uncertain significance (Sep 29, 2022) | ||
22-30292560-G-A | not specified | Uncertain significance (Jun 13, 2024) | ||
22-30292566-C-T | not specified | Uncertain significance (Feb 16, 2023) | ||
22-30292614-G-C | not specified | Uncertain significance (May 21, 2024) | ||
22-30292634-G-A | not specified | Uncertain significance (Oct 04, 2022) | ||
22-30292655-G-T | not specified | Uncertain significance (Mar 25, 2024) | ||
22-30292670-C-T | Benign (Apr 19, 2019) | |||
22-30292751-G-A | not specified | Uncertain significance (Apr 07, 2023) | ||
22-30292758-G-A | not specified | Likely benign (Jan 08, 2024) | ||
22-30292773-C-T | not specified | Uncertain significance (Jan 02, 2024) | ||
22-30292790-C-T | not specified | Uncertain significance (Mar 25, 2024) | ||
22-30292794-G-A | not specified | Uncertain significance (Nov 03, 2023) | ||
22-30292826-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
22-30293653-C-T | not specified | Uncertain significance (Jan 10, 2023) | ||
22-30293697-C-T | not specified | Uncertain significance (Apr 23, 2024) | ||
22-30293706-T-A | not specified | Uncertain significance (Dec 05, 2022) | ||
22-30293708-G-C | not specified | Uncertain significance (Dec 22, 2023) | ||
22-30293710-T-C | not specified | Uncertain significance (Jun 06, 2023) | ||
22-30293716-C-T | not specified | Uncertain significance (Aug 09, 2021) | ||
22-30293751-G-A | not specified | Uncertain significance (Sep 22, 2022) | ||
22-30293767-T-G | not specified | Uncertain significance (Mar 21, 2022) | ||
22-30293770-G-C | not specified | Uncertain significance (Dec 05, 2022) | ||
22-30294004-A-G | not specified | Uncertain significance (Feb 07, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TBC1D10A | protein_coding | protein_coding | ENST00000403477 | 9 | 35057 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00429 | 0.995 | 125719 | 0 | 24 | 125743 | 0.0000954 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.25 | 256 | 319 | 0.803 | 0.0000201 | 3317 |
Missense in Polyphen | 55 | 91.969 | 0.59803 | 896 | ||
Synonymous | 0.168 | 129 | 131 | 0.981 | 0.00000799 | 1040 |
Loss of Function | 3.17 | 9 | 26.7 | 0.337 | 0.00000132 | 280 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000290 | 0.0000290 |
Ashkenazi Jewish | 0.000101 | 0.0000992 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.000326 | 0.000323 |
European (Non-Finnish) | 0.0000796 | 0.0000791 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as GTPase-activating protein for RAB27A, but not for RAB2A, RAB3A, nor RAB4A. {ECO:0000269|PubMed:16923811}.;
- Pathway
- Deregulation of Rab and Rab Effector Genes in Bladder Cancer;Vesicle-mediated transport;TBC/RABGAPs;Membrane Trafficking;Rab regulation of trafficking
(Consensus)
Recessive Scores
- pRec
- 0.130
Intolerance Scores
- loftool
- 0.336
- rvis_EVS
- -0.4
- rvis_percentile_EVS
- 26.85
Haploinsufficiency Scores
- pHI
- 0.481
- hipred
- N
- hipred_score
- 0.481
- ghis
- 0.543
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.797
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tbc1d10a
- Phenotype
- liver/biliary system phenotype; homeostasis/metabolism phenotype; cellular phenotype;
Gene ontology
- Biological process
- intracellular protein transport;retrograde transport, endosome to Golgi;positive regulation of proteolysis;activation of GTPase activity;activation of cysteine-type endopeptidase activity;regulation of cilium assembly
- Cellular component
- cytosol;plasma membrane;microvillus;extracellular exosome
- Molecular function
- guanyl-nucleotide exchange factor activity;GTPase activator activity;protein binding;Rab GTPase binding;PDZ domain binding;cadherin binding